Bo Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bo Lu has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Yueli Zhang
School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan 430070, People's Republic of China
7 shared publicationsYuqi Chen
School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan 430070, People's Republic of China
7 shared publicationsChaohua Li
School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan, People’s Republic of China
6 shared publicationsJingrui Chang
School of Chemistry, Department of Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan, 430070, China
6 shared publicationsQingni Xu
School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan, People’s Republic of China
6 shared publicationsXinyu Wang
School of Chemistry, Department of Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan, 430070, China
6 shared publications
Latest Publications
- 5 January 2026
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 10 (1) , 112-123
Self-healing photothermal antibacterial hydrogels constructed through multiple dynamic chemical bonds
Hydrogels, with their highly hydrophilic, three-dimensional polymer network structure, offer great potential as antimicrobial biomedical materials.
- 5 January 2026
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 10 (1) , 112-123
Self-healing photothermal antibacterial hydrogels constructed through multiple dynamic chemical bonds
Hydrogels, with their highly hydrophilic, three-dimensional polymer network structure, offer great potential as antimicrobial biomedical materials.
- 26 December 2025
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 41 (1) , 3-28
Application of hollow manganese dioxide in cancer diagnosis and treatment
Malignant tumors pose a serious threat to human health. They are characterized by high incidence and indistinct early symptoms. Advances in medical technology have revealed the limitations of conventional therapies. Consequently, precision, minimally invasive, and integrated diagnosis and treatment have become key objectives in modern oncology. Nanomedicine shows considerable potential for precision therapy. However, novel nanocarriers that combine high efficiency, precise targeting, controllable drug release, and excellent biocompatibility are still urgently needed. Hollow manganese dioxide is a promising inorganic nanomaterial. It exhibits high drug loading capacity, responsiveness to the tumor microenvironment, and favorable biocompatibility. These properties make it an excellent drug carrier for cancer therapy. Synthetic methods for constructing MnO 2 -based multifunctional nanoplatforms continue to advance. This review highlights promising applications of hollow MnO 2 in drug delivery, bioimaging, and biosensing. Finally, we summarize the associated challenges and future prospects in anticancer applications, aiming to provide meaningful guidance for further research.p
- 26 December 2025
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 41 (1) , 3-28
Application of hollow manganese dioxide in cancer diagnosis and treatment
Malignant tumors pose a serious threat to human health. They are characterized by high incidence and indistinct early symptoms. Advances in medical technology have revealed the limitations of conventional therapies. Consequently, precision, minimally invasive, and integrated diagnosis and treatment have become key objectives in modern oncology. Nanomedicine shows considerable potential for precision therapy. However, novel nanocarriers that combine high efficiency, precise targeting, controllable drug release, and excellent biocompatibility are still urgently needed. Hollow manganese dioxide is a promising inorganic nanomaterial. It exhibits high drug loading capacity, responsiveness to the tumor microenvironment, and favorable biocompatibility. These properties make it an excellent drug carrier for cancer therapy. Synthetic methods for constructing MnO 2 -based multifunctional nanoplatforms continue to advance. This review highlights promising applications of hollow MnO 2 in drug delivery, bioimaging, and biosensing. Finally, we summarize the associated challenges and future prospects in anticancer applications, aiming to provide meaningful guidance for further research.p
- 24 November 2025
- Published by Springer Nature in Journal of Nanoparticle Research
- Vol. 27 (12) , 308
Research on the photothermal-chemotherapy synergistic anti-tumor effect of a multifunctional nanoenzyme drug delivery platform
- 24 November 2025
- Published by Springer Nature in Journal of Nanoparticle Research
- Vol. 27 (12) , 308
Research on the photothermal-chemotherapy synergistic anti-tumor effect of a multifunctional nanoenzyme drug delivery platform
- 19 September 2025
- Published by Springer Nature in Frontiers of Materials Science
- Vol. 19 (3) , 1-27
Recent advances in crosslinking strategies for designing self-healing hydrogels in biomedical applications: a review
- 19 September 2025
- Published by Springer Nature in Frontiers of Materials Science
- Vol. 19 (3) , 1-27
Recent advances in crosslinking strategies for designing self-healing hydrogels in biomedical applications: a review
- 11 November 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (46) , 19462-19471
HAase/GSH dual-responsive mesoporous organosilica nanoparticles for synergistic photodynamic/photothermal/pharmacological antibacterial therapy
Mesoporous organosilica nanoparticles (MONs) are promising drug carriers with excellent biocompatibility and biodegradability. In the context of the bacterial infection microenvironment, a hyaluronidase (HAase)/glutathione (GSH) dual-responsive degradable nanoplatform based on MON (ICG/CIP@MON@PEI-HA) has been developed for the multimodal treatment of bacterial infection. In this work, ciprofloxacin (CIP) and indocyanine green (ICG) are physically adsorbed into the MON, polyethyleneimine (PEI) is electrostatically adsorbed onto the MON surface, and hyaluronic acid (HA) is grafted onto the amino groups of PEI via the amide bonds. The overexpression of HAase at bacterial infection sites enables HA shell degradation, and positively charged PEI is exposed, which facilitates nanoparticle binding to negatively charged bacteria. Also, owing to the protonation of amine groups, PEI is swelled in the acidic environment of bacterial infection, which favours drug release. Subsequently, overexpressed GSH breaks the disulfide bonds in the MON, triggering structural degradation that inhibits carrier accumulation and accelerates drug release even further. According to in vitro antibacterial evaluations, the antibacterial effect can be enhanced to 100% when phototherapy and pharmaceutical therapy are combined. In vitro cytotoxicity assays have demonstrated that ICG/CIP@MON@PEI-HA possesses excellent biocompatibility. Therefore, this study offers a potential approach for developing biodegradable nanoplatforms for the combined treatment of bacterial infection.
- 11 November 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (46) , 19462-19471
HAase/GSH dual-responsive mesoporous organosilica nanoparticles for synergistic photodynamic/photothermal/pharmacological antibacterial therapy
Mesoporous organosilica nanoparticles (MONs) are promising drug carriers with excellent biocompatibility and biodegradability. In the context of the bacterial infection microenvironment, a hyaluronidase (HAase)/glutathione (GSH) dual-responsive degradable nanoplatform based on MON (ICG/CIP@MON@PEI-HA) has been developed for the multimodal treatment of bacterial infection. In this work, ciprofloxacin (CIP) and indocyanine green (ICG) are physically adsorbed into the MON, polyethyleneimine (PEI) is electrostatically adsorbed onto the MON surface, and hyaluronic acid (HA) is grafted onto the amino groups of PEI via the amide bonds. The overexpression of HAase at bacterial infection sites enables HA shell degradation, and positively charged PEI is exposed, which facilitates nanoparticle binding to negatively charged bacteria. Also, owing to the protonation of amine groups, PEI is swelled in the acidic environment of bacterial infection, which favours drug release. Subsequently, overexpressed GSH breaks the disulfide bonds in the MON, triggering structural degradation that inhibits carrier accumulation and accelerates drug release even further. According to in vitro antibacterial evaluations, the antibacterial effect can be enhanced to 100% when phototherapy and pharmaceutical therapy are combined. In vitro cytotoxicity assays have demonstrated that ICG/CIP@MON@PEI-HA possesses excellent biocompatibility. Therefore, this study offers a potential approach for developing biodegradable nanoplatforms for the combined treatment of bacterial infection.
- 21 October 2024
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 53 (44) , 17893-17901
An acidity-triggered aggregation nanoplatform based on degradable mesoporous organosilica nanoparticles for precise drug delivery and phototherapy of focal bacterial infection
An acidity-triggered aggregation antibacterial nanoplatform based on biodegradable mesoporous organic silica nanoparticles, is reported. It enables precise drug release and spatial accuracy for photodynamic therapy and photothermal therapy.
- 21 October 2024
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 53 (44) , 17893-17901
An acidity-triggered aggregation nanoplatform based on degradable mesoporous organosilica nanoparticles for precise drug delivery and phototherapy of focal bacterial infection
An acidity-triggered aggregation antibacterial nanoplatform based on biodegradable mesoporous organic silica nanoparticles, is reported. It enables precise drug release and spatial accuracy for photodynamic therapy and photothermal therapy.
- 15 February 2024
- Published by Wiley in Particle & Particle Systems Characterization
- Vol. 41 (6)
A pH/GSH Dual‐Responsive, Folic Acid Targeted Drug Delivery System Based on Bovine Serum Albumin Nanoparticles for Cancer Therapy
Bovine serum albumin, based on its low toxicity and excellent biocompatibility, has great potential as a carrier for drug delivery systems. In this context, a pH/GSH dual‐responsive drug delivery system (ICG/DOX@Fe‐BSA‐FA nanoparticles) based on Bovine serum albumin (BSA) is constructed for tumor‐targeted multimodal therapy. In this study, doxorubicin (DOX) and indocyanine green (ICG) are co‐loaded after Fe3+ is coordinated with BSA, and the system is finally grafted with the targeted molecule Folic acid. DOX is used in chemotherapy, ICG is used in photodynamic therapy (PDT) and photothermal therapy (PTT), and Fe3+ mainly provided sufficient raw material for the Fenton‐like reaction. The ability of ICG/DOX@Fe‐BSA‐FA (ID@FBF) nanoparticles to combine chemotherapy with CDT/PDT/PTT is demonstrated by several physical characterization. In vitro cell uptake assay and in vitro cytotoxicity assay demonstrated the excellent ability of ID@FBF to target 4T1 cells and kill tumor cells with the IC50 value of 0.75 µg mL−1. Therefore, chemotherapy combined with CDT/PDT/PTT therapy may result in satisfactory efficacy via ID@FBF, a potentially powerful and highly effective nanosystem.
- 15 February 2024
- Published by Wiley in Particle & Particle Systems Characterization
- Vol. 41 (6)
A pH/GSH Dual‐Responsive, Folic Acid Targeted Drug Delivery System Based on Bovine Serum Albumin Nanoparticles for Cancer Therapy
Bovine serum albumin, based on its low toxicity and excellent biocompatibility, has great potential as a carrier for drug delivery systems. In this context, a pH/GSH dual‐responsive drug delivery system (ICG/DOX@Fe‐BSA‐FA nanoparticles) based on Bovine serum albumin (BSA) is constructed for tumor‐targeted multimodal therapy. In this study, doxorubicin (DOX) and indocyanine green (ICG) are co‐loaded after Fe3+ is coordinated with BSA, and the system is finally grafted with the targeted molecule Folic acid. DOX is used in chemotherapy, ICG is used in photodynamic therapy (PDT) and photothermal therapy (PTT), and Fe3+ mainly provided sufficient raw material for the Fenton‐like reaction. The ability of ICG/DOX@Fe‐BSA‐FA (ID@FBF) nanoparticles to combine chemotherapy with CDT/PDT/PTT is demonstrated by several physical characterization. In vitro cell uptake assay and in vitro cytotoxicity assay demonstrated the excellent ability of ID@FBF to target 4T1 cells and kill tumor cells with the IC50 value of 0.75 µg mL−1. Therefore, chemotherapy combined with CDT/PDT/PTT therapy may result in satisfactory efficacy via ID@FBF, a potentially powerful and highly effective nanosystem.
- 23 August 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (41) , 9798-9839
Cascade strategy for glucose oxidase-based synergistic cancer therapy using nanomaterials
Nanomaterial-based cancer therapy faces significant limitations due to the complex nature of the tumor microenvironment (TME). Starvation therapy is an emerging therapeutic approach that targets tumor cell metabolism using glucose oxidase (GOx). Importantly, it can provide a material or environmental foundation for other diverse therapeutic methods by manipulating the properties of the TME, such as acidity, hydrogen peroxide (H2O2) levels, and hypoxia degree. In recent years, this cascade strategy has been extensively applied in nanoplatforms for ongoing synergetic therapy and still holds undeniable potential. However, only a few review articles comprehensively elucidate the rational designs of nanoplatforms for synergetic therapeutic regimens revolving around the conception of the cascade strategy. Therefore, this review focuses on innovative cascade strategies for GOx-based synergetic therapy from representative paradigms to state-of-the-art reports to provide an instructive, comprehensive, and insightful reference for readers. Thereafter, we discuss the remaining challenges and offer a critical perspective on the further advancement of GOx-facilitated cancer treatment toward clinical translation.
- 23 August 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (41) , 9798-9839
Cascade strategy for glucose oxidase-based synergistic cancer therapy using nanomaterials
Nanomaterial-based cancer therapy faces significant limitations due to the complex nature of the tumor microenvironment (TME). Starvation therapy is an emerging therapeutic approach that targets tumor cell metabolism using glucose oxidase (GOx). Importantly, it can provide a material or environmental foundation for other diverse therapeutic methods by manipulating the properties of the TME, such as acidity, hydrogen peroxide (H2O2) levels, and hypoxia degree. In recent years, this cascade strategy has been extensively applied in nanoplatforms for ongoing synergetic therapy and still holds undeniable potential. However, only a few review articles comprehensively elucidate the rational designs of nanoplatforms for synergetic therapeutic regimens revolving around the conception of the cascade strategy. Therefore, this review focuses on innovative cascade strategies for GOx-based synergetic therapy from representative paradigms to state-of-the-art reports to provide an instructive, comprehensive, and insightful reference for readers. Thereafter, we discuss the remaining challenges and offer a critical perspective on the further advancement of GOx-facilitated cancer treatment toward clinical translation.
- 11 February 2023
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 224, 113201
Bovine serum albumin-based and dual-responsive targeted hollow mesoporous silica nanoparticles for breast cancer therapy
- 11 February 2023
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 224, 113201
Bovine serum albumin-based and dual-responsive targeted hollow mesoporous silica nanoparticles for breast cancer therapy
- 31 December 2022
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 247, 115084
Manipulate tumor hypoxia for improved photodynamic therapy using nanomaterials
- 31 December 2022
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 247, 115084
Manipulate tumor hypoxia for improved photodynamic therapy using nanomaterials